Nanotechnological Applications in Virology explores the use of nanoparticles-based technologies to fight against viruses, also discussing the use of nanoparticles in the preparation of nano masks and as sanitizing agents. The role of nanotechnology against HIV, Hepatitis, Influenza, Herpes, Ebola and Zika using rapid detection and diagnostic techniques is included, as is a brief description of SARS, MERS, the novel Coronavirus, and recent advancements in its treatment process. Other sections cover the formulation of novel nano-vaccines for the treatment and control of viral infections like HIV, Hepatitis and COVID-19. Included toxicological studies of nanoparticles provide readers with a brief overview on global scenarios regarding viral infections.
Nanotechnology is the present age technology, with wide usage in different areas of medical science, including drug delivery, gene therapy, antimicrobials, biosensors and bio-labelling. Nanoparticles play a competent role as an anti-infection agent and thus act as efficient antiviral agents.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Nanotechnology and its potential role against viruses 2. Nanotechnology based innovations to fight against viral infections 3. Functionalized metal and metal oxide nanoparticles/nanocomposites against viruses 4. Unique advantages of nanomaterials in drug delivery and therapy against viruses 5. Engineered nanoparticles for therapeutic applications 6. Intranasal delivery of nanoparticles in HIV:�A revolution in therapeutics 7. Application of Nanomaterials as Nanomasks 8. Nanomaterials as Sanitizing Agents
Section II Nanotechnology for Detection and Inhibition of Viral Infections 9. Harnessing nanotechnology for visualizing viruses and host-pathogen interactions 10. Nanotechnological tools for the inhibition of Ebola, Zika and Herpes Simplex virus 11. Nanotechnology: New frontiers in anti HIV therapy 12. Nanoparticles based immunoassays for early and rapid detection of HIV and other viral?infections 13. Nanobiotechnology: The union of Sciences in the fight against viruses
Section III Nanotechnology against Novel Coronavirus 14. SARS, MERS and COVID-19: Emerging threats to public health 15. Origin, evolution and pathogenesis of Corona virus 16. Recent advancements in diagnosis, treatment and vaccination for COVID-19
Section IV Nanotechnology-based Vaccines 17. Nanoformulated vaccines against viral infections: a review 18. Development of novel vaccines using nanomaterials against COVID-19
Section V Toxicological challenges 19. Toxicological considerations of use of nanoparticles in the treatment of viral infections
Authors
Mahendra Rai Visiting Scientist, Nicolaus Copernicus University, Torun, Poland.Professor Mahendra Rai is a UGC-Basic Science Research Faculty Fellow and former head of the Department of Biotechnology, Sant Gadge Baba Amravati University, India. Presently, he is a visiting Scientist at the Department of Microbiology, Nicolaus Copernicus University, Poland. His areas of expertise include microbial biotechnology and nanobiotechnology. Currently, his group's main research interest is green synthesis of metal nanoparticles particularly using fungi and their applications as nanoantimicrobials against pathogenic microbes. Prof. Rai has received several prestigious awards, including the Medini Award by the Government of India. He has been featured in Stanford's list of the top 2% of scientists in nanoscience.
Alka Yadav Department of Biotechnology, SGB Amravati University, India. Dr Yadav PhD has 10 years of experience in publishing research and review articles in high impact factor journals. She has worked as guest reviewer in prestigious science publications such as Springer, Wiley, Taylor and Frances and has been recognized by Elsevier for her article Silver nanoparticles: as a new generation of antimicrobials which has been cited over 5000 times. She has several book chapters along with a process patent to her credit
